Diagnostics

Therapeutic drug monitoring (TDM) is used to measure the concentration of an active ingredient in the patient’s blood. Using this information, physicians can adjust the dose individually to the [...]

Tick season has started and the risk of dangerous infections with TBE/FSME is increasing. In the event of a suspected infection and to clarify immunization, antibody detection is the method of choice.

As every year, March is officially “Colon Cancer Awareness Month”. A great opportunity to highlight the importance of screening. Nowadays, modern tests have made the early detection of [...]

So-called TNFα blockers are commonly used in the treatment of inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Therapeutic drug monitoring improves the effect of [...]

RIDA®GENE Helicobacter pylori is a sensitive and specific real-time PCR assay. It simultaneously detects and differentiates Helicobacter pylori and its resistance to clarithromycin in human [...]

The new assay RIDASCREEN ® Legionella of R-Biopharm closes the gap in test portfolio for the detection of life-threatening infectious diseases.

R-Biopharm starts RIDA qLine® Allergy External Quality Assessment. This new tool will help to ensure the quality of the testing procedures in laboratories using RIDA qLine® Allergy and the [...]

The RIDA®GENE real-time PCR assays  (RIDA®GENE Flu, RIDA®GENE Flu LC2.0, RIDA®GENE Flu & RSV)  successfully detected the suggested vaccination strains for influenca of the 2015/2016 season.

Chronic inflammatory bowel disease (IBD) is characterized by recurring and often ongoing flares. The most common forms of IBD are Crohns disease and Ulcerative colitis.

Almost 50 % of type one diabetics and about 33 % of type 2 diabetics will develop a pancreatic insufficiency in the course of their disease.